@MYTH©bubu et les 4 doses !

 MYTH©bubu  : Vous êtes à la recherche de ce genre d’études ? : https://www.nejm.org/doi/full/10.1056/NEJMoa2117995

Vous arrivez à appeler ce publi-réportage de Kill Pharma étude sans vous rouler par terre de rire ???

Case patients were selected among adolescents who were hospitalized with Covid-19 as the primary reason for admission or who had a clinical syndrome consistent with acute Covid-19 (one or more symptoms of fever, cough, shortness of breath, loss of taste, loss of smell, gastrointestinal symptoms, respiratory support, or new pulmonary findings on chest imaging). All case patients had positive results for SARS-CoV-2 on reverse transcriptase–polymerase-chain-reaction (RT-PCR) assay or on antigen testing 

those without Covid-19–like symptoms who may or may not have undergone SARS-CoV-2 testing

Patients were considered to have received Covid-19 vaccination based on source documentation or by plausible self-report

Among the case patients, the median age was 16 years, 74% had at least one underlying condition (including obesity), and 70% attended an in-person school

Among the controls, the median age was 15 years, 70% had at least one underlying condition, and 70% attended an in-person school.

Underlying conditions, which included obesity, were common, both among adolescents who were vaccinated (73%) and those who were unvaccinated (71%). Respiratory and endocrine disorders were more prevalent among case patients than among controls ; neurologic or neuromuscular disorders and immunosuppressive or autoimmune disorders were more prevalent among controls than among case patients.

 

RAISON PRINCIPALE DE L’ADMISSION À L’HÔPITAL :

TABLE S2. Primary admission diagnosis among 37 hospitalized patients* with SARS-CoV-2 positive test who were hospitalized for a non-COVID-19 reason

Psychiatric admission (41%) / Trauma (24%) / Shunt malfunction (8%) / Abscess (3%) / Cellulitis (3%) / Cholelithiasis (3%) / Feeding tube malfunction (3%) / Gynecologic (3%) / Medication infusion (3%) / New cancer diagnosis (3%) / Post-operative complication (3%) / Suicidal ideation (3%) / Trauma (3%)

 

COMORBIDITÉS :

TABLE S3. Underlying conditions and vaccination status among COVID-19 case-patients with ECMO or death

1 Respiratory system disorder, asthma, other chronic condition* / 2 Respiratory system disorder, asthma, endocrine disorder, Type I

diabetes, other chronic condition* / 3 Respiratory system disorder, asthma, other chronic condition* / 4 Endocrine disorder, Type II diabetes, other chronic condition* / 5 Respiratory system disorder and asthma / 6 Respiratory system disorder and other chronic condition* / 7 Disorder of cardiovascular system and other chronic condition* / 8 Respiratory system disorder and asthma / 9 Disorder of cardiovascular system, endocrine disorder, other chronic condition* / 10 Other chronic condition* / 11 Other chronic condition* / 12 Respiratory system disorder, asthma, endocrine disorder / 13 Respiratory system disorder, Endocrine disorder, Type II Diabetes, other chronic condition* / 14 Endocrine disorder, Type I Diabetes / 15 Disorder of cardiovascular system, neurologic or neuromuscular disorder, non-oncologic immunosuppressive disorder, endocrine disorder, other chronic condition* / 16 Endocrine disorder, Type II diabetes

*Other chronic conditions included, but not limited to, obesity, rheumatologic/autoimmune disorder, hematologic disorder, renal or urologic dysfunction, gastrointestinal/hepatic disorder, metabolic or confirmed or suspected genetic disorder, or atopic or allergic condition.

Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents

January 12, 2022 - DOI : 10.1056/NEJMoa2117995

 « par contre la vaccination tout les 6 mois je vous arrête tout de suite, la 3eme dose je trouve déjà que ce n’est pas solution de la généraliser à tout le monde d’un coup comme ca alors si demain on m’explique que tout les 6 mois faut me vacciner non ca ne va pas me convenir  »

Auteur anonyme, première moitié du XXIe siècle

Heil Μπουρλά !